You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Drug Therapy, Combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Carcinoma Trial in Duarte (procedure, drug, other)

Not yet recruiting
  • Advanced Prostate Carcinoma
  • +4 more
  • Bright White Light Therapy
  • +4 more
  • Duarte, California
    City of Hope Medical Center
May 8, 2023

Newly Diagnosed Glioblastoma Trial (combinations of up to 3 FDA approved drugs from a panel of compounds)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • combinations of up to 3 FDA approved drugs from a panel of compounds
  • (no location specified)
Jan 19, 2023

Non-healing Wound, Non-Healing Ulcer of Skin Trial in Santa Fe (Omeza Products Used in Combination)

Recruiting
  • Non-healing Wound
  • Non-Healing Ulcer of Skin
  • Omeza Products Used in Combination
  • Santa Fe, New Mexico
    Christus St. Vincent
Jun 19, 2023

Uncomplicated Plasmodium Falciparum Malaria Trial in Bagamoyo (Artemether-lumefantrine and Amodiaquine Drug Combination,

Not yet recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • Artemether-lumefantrine and Amodiaquine Drug Combination
  • +2 more
  • Bagamoyo, Dar esSalaam, Tanzania
  • +1 more
Feb 28, 2023

Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation Trial in Seoul

Not yet recruiting
  • Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation
  • ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg)
  • high-intensity statin monotherapy (atoravastatin 40mg)
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 21, 2023

Monitoring Drug Efficacy in Patients With Alzheimer's Disease

Recruiting
  • Alzheimer Disease
  • AChE inhibitor monotherapy
  • AChE inhibitor and NMDA receptor antagonist combination therapy
  • Manila, Metro Manila, Philippines
    Philippine General Hospital
Mar 24, 2023

Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases

Not yet recruiting
  • Multi-Drug Resistant Hiv-1 Infection
  • HIV-1 Infection
  • UB-421
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Hangzhou, Zhejiang, China
    Department of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023

Femoropopliteal Artery Disease Trial in Seoul (Combination therapy of atherectomy and DCB, DCB alone)

Not yet recruiting
  • Femoropopliteal Artery Disease
  • Combination therapy of atherectomy and DCB
  • DCB alone
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 23, 2022

Multiple Cancer, Colorectal Cancer Trial (MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 mAb neoadjuvant

Not yet recruiting
  • Multiple Cancer
  • Colorectal Cancer
  • MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 monoclonal antibody neoadjuvant therapy
  • All-MSI-H (dMMR) sMPCC: single-drug PD-1 monoclonal antibody neoadjuvant therapy
  • (no location specified)
Aug 20, 2023

Prostatic Tumors, Castration-Resistant, Drug Therapy, Combination Trial in Chengdu (TQB3616 Capsules Combined With Abiraterone

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Drug Therapy, Combination
  • TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone
  • Chengdu, Sichuan, China
    West China Hospital
Dec 12, 2021

Diabetic Peripheral Neuropathy Trial in Jedda (Group- A (100% weight-bearing; n=14), (moderate-intensity (50-70% heart rate

Completed
  • Diabetic Peripheral Neuropathy
  • Group- A (100% weight-bearing; n=14), (moderate-intensity (50-70% heart rate reserve) aerobic exercise training on the antigravity treadmill, 3 times/week for 12-weeks.
  • +4 more
  • Jedda, Saudi Arabia
    Umm Al-Qura University
Sep 29, 2022

Congenital Adrenal Hyperplasia (CAH) Trial run by the NICHD (Flutamide, Letrozole, Hydrocortisone)

Active, not recruiting
  • Congenital Adrenal Hyperplasia (CAH)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma

Recruiting
  • Mesothelioma, Malignant
    • Shinjuku-ku, Tokyo, Japan
      Local Institution
    Apr 5, 2022

    Huaier Granules in Postoperative Adjuvant Therapy for Non-small

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Huaier granule
    • Control
    • Shenyang, Liaoning, China
      Liaoning Cancer Hospital & Institute
    Oct 27, 2023

    Coronary Artery Disease, Dyslipidemias Trial in Yongin (a high dose of statin/ezetimib)

    Recruiting
    • Coronary Artery Disease
    • Dyslipidemias
    • a high dose of statin/ezetimib
    • Yongin, Gyeonggi-do, Korea, Republic of
      Yongin Severance Hospital
    Jun 14, 2023

    HIV Trial (Tetanus Toxoid Vaccine, Hydroxyurea, Didanosine)

    Withdrawn
    • HIV Infections
    • Tetanus Toxoid Vaccine
    • +2 more
    • (no location specified)
    Oct 28, 2021

    COVID-19 Trial in Mansoura (Casirivimab and Imdevimab Drug Combination, Remdesivir, Favipiravir)

    Completed
    • COVID-19
    • Casirivimab and Imdevimab Drug Combination
    • +2 more
    • Mansoura, El-dkhalia, Egypt
      El-gomhoria St
    Aug 13, 2022

    Lung Cancer Trial in Korea, Republic of (Olaparib+Bevacizumab to SCLC patients)

    Recruiting
    • Lung Cancer
    • Olaparib+Bevacizumab to SCLC patients
    • Seoul, Gangnam-gu, Korea, Republic of
    • +3 more
    Nov 9, 2022

    Carbapenem Resistant Klebsiella Pneumoniae Trial in Ratchathewi (Dose-adjustment by PKPD)

    Recruiting
    • Carbapenem Resistant Klebsiella Pneumoniae
    • Dose-adjustment by PKPD
    • Ratchathewi, Bangkok, Thailand
      Phramongkutklao Hospital
    May 7, 2023

    Benign Prostatic Hyperplasia (BPH) Trial in France (REZUM, alpha blocker and 5-alpha reductase inhibitor)

    Recruiting
    • Benign Prostatic Hyperplasia (BPH)
    • REZŪM
    • alpha blocker and 5-alpha reductase inhibitor
    • Aix-en-Provence, France
    • +9 more
    Jul 26, 2022

    Chronic Hepatitis B Trial in Seoul (Standard of care)

    Active, not recruiting
    • Chronic Hepatitis B
    • Standard of care
    • Seoul, Korea, Republic of
    • +3 more
    Mar 29, 2023

    Colchicine and Nonsteroidal Anti-inflammatory Drug Combination

    Active, not recruiting
    • Renal Impairment
    • +3 more
    • Colchicine and NSAID
    • (no location specified)
    Aug 12, 2021

    OSA, Obstructive Sleep Apnea Trial in La Jolla (Acetazolamide, Eszopiclone, Placebo)

    Recruiting
    • OSA
    • Obstructive Sleep Apnea
    • La Jolla, California
    • +1 more
    Sep 22, 2021

    Diffuse Intrinsic Pontine Glioma Trial in Phoenix, San Francisco, Washington (SONALA-001 (ALA) and MR-Guided Focused Ultrasound

    Recruiting
    • Diffuse Intrinsic Pontine Glioma
    • SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
    • Phoenix, Arizona
    • +2 more
    Jan 4, 2023